The Challenge
Micelle BioPharma retained PharmaBioSource Realty as its exclusive real estate broker to divest its FDA-licensed 73,550-square-foot soft gelatin capsule development and manufacturing assets and facility lease in Riviera Beach, Florida.
The Solution
PharmaBioSource Realty marketed the assets and facility lease to strategic acquirers.
Services provided by the PharmaBioSource Realty team:
- Benchmark valuation
- Buyer target identification and engagement
- Creation of the Confidential Information Memorandum (CIM)
- Data room development
- Due diligence support
- Negotiations and closing support
The Results
PharmaBioSource Realty identified Strides as the acquirer. Strides acquired the assets along with the facility lease to establish its U.S. soft gel manufacturing presence.
What We Did
Sell-Side Advisory
Divestiture